Letters β blockers and mortality in COPD

Author’s reply to Wolstenholme and Sanfilippo and colleagues

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1132 (Published 29 January 2014) Cite this as: BMJ 2014;348:g1132
  1. Jennifer K Quint, clinical lecturer and honorary consultant1
  1. 1Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
  1. jennifer.quint{at}lshtm.ac.uk

The responders have highlighted some important issues that merit further investigation.1 2 3 4

We agree with Wolstenholme that it seems counterintuitive to use β blockers and β agonists in patients with chronic obstructive pulmonary disease (COPD), but most patients in our study were prescribed cardioselective β blockers, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe